Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Acupressure eases heart Patients' anxiety, study finds

NCT ID NCT06300294

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether acupressure, a technique that applies pressure to specific points on the body, can reduce anxiety and improve vital signs like blood pressure and heart rate in people hospitalized with acute coronary syndrome (ACS). Sixty-eight adults with a first-time ACS diagnosis participated. Researchers measured anxiety, pain, and physiological parameters before and after acupressure. The goal was to see if this simple, non-invasive method could help patients feel calmer and stabilize their health during a critical time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

68 people

The number who actually took part.

Started

May 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Volunteer to participate in the study, * Those aged 18 and over * Able to speak Turkish * Diagnosed with ACS for the first time * Cardiopulmonary resuscitation not applied * No orientation problems (those who score 15 on the Glasgow Coma Scale) * Not diagnosed with psychiatric disease * No amputation, fistula, lymphedema, neuropathy or hemiplegia in any of the Upper Extremities * Those who underwent femoral intervention for CAG procedure * Those who have not used any integrative practices based on pressure and stimulation such as acupressure, acupuncture and reflexology in the last month. * Vital signs (28) are within normal range: Blood pressure: 90/60-120/80 mmHg Heart rate: 60-100 min Respiratory rate: 12-18 min Exclusion Criteria: * Those with arrhythmia (AF, VT etc.) * Patients who have previously undergone Coronary Angiography * Diagnosed with myocarditis, pericarditis * Those who do not take any speed-breaking drugs (beloc, arlec, etc.). * Patients who underwent radial intervention for CAG procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Manisa City Hospital

    Manisa, 45000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.